UTAH MEDICAL PRODUCTS INC
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $42.0M | $41.4M | $39.3M | $40.2M | $41.3M | $40.5M | $41.6M | $37.9M |
| Cost of Revenue | $15.7M | $15.0M | $15.6M | $16.0M | $16.3M | $16.2M | $16.2M | $15.5M |
| Gross Profit | $26.3M | $26.4M | $23.7M | $24.2M | $25.0M | $24.3M | $25.3M | $22.4M |
| Gross Margin | 62.6% | 63.7% | 60.3% | 60.2% | 60.5% | 59.9% | 60.9% | 59.2% |
| Operating Expenses | ||||||||
| Research & Development | $454.0K | $447.0K | $475.0K | $522.0K | $460.0K | $491.0K | $563.0K | $-518.0K |
| SG&A Expense | $5.4M | $5.4M | $5.4M | $5.8M | $6.1M | $6.2M | $6.8M | $-7.2M |
| Operating Income | $18.7M | $19.0M | $16.2M | $15.7M | $16.2M | $14.8M | $15.2M | $11.8M |
| Operating Margin | 44.5% | 45.9% | 41.2% | 39.0% | 39.3% | 36.6% | 36.6% | 31.3% |
| Interest Expense | — | — | — | $65.0K | $289.0K | $438.0K | $652.0K | $859.0K |
| Pretax Income | $19.5M | $19.1M | $16.4M | $15.5M | $15.8M | $14.5M | $14.5M | $11.1M |
| Income Tax Expense | $904.0K | $10.6M | $4.3M | $3.7M | $4.4M | $3.1M | $4.4M | $3.7M |
| Net Income | $18.6M | $8.5M | $12.1M | $11.8M | $11.4M | $11.4M | $10.2M | $7.4M |
| Net Margin | 44.2% | 20.5% | 30.9% | 29.5% | 27.6% | 28.2% | 24.5% | 19.6% |
| EPS (Basic) | $4.97 | $2.29 | $3.23 | $3.16 | $3.04 | $3.06 | $2.77 | $2.04 |
| EPS (Diluted) | $4.95 | $2.28 | $3.22 | $3.14 | $3.02 | $3.02 | $2.74 | $2.03 |
| Shares Outstanding (Basic) | 3.7M | 3.7M | 3.8M | 3.8M | 3.7M | 3.7M | 3.7M | 3.6M |
| Shares Outstanding (Diluted) | 3.7M | 3.7M | 3.8M | 3.8M | 3.8M | 3.8M | 3.7M | 3.6M |
| Dividends Per Share | — | — | — | — | — | — | — | — |